We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

12 hedge funds and large institutions have $758K invested in Viking Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.16% more ownership

Funds ownership: 0% → 3.16% (+3.2%)

14% less funds holding

Funds holding: 14 → 12 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

55% less capital invested

Capital invested by funds: $1.7M → $758K (-$944K)

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$160K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$69.9K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$56.3K
4
Goldman Sachs
Goldman Sachs
New York
+$33K
5
Morgan Stanley
Morgan Stanley
New York
+$16.9K

Top Sellers

1
SCM
Sio Capital Management
New York
-$1.19M
2
VKH
Virtu KCG Holdings
New York
-$33K
3
Wells Fargo
Wells Fargo
California
-$9K
4
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$322K +$56.3K +49,926 +23%
Renaissance Technologies
2
Renaissance Technologies
New York
$194K +$160K +141,900 +666%
SKK
3
Shepherd Kaplan Krochuk
Massachusetts
$113K +$69.9K +61,978 +188%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$37K – – –
Goldman Sachs
5
Goldman Sachs
New York
$35K +$33K +29,239 New
Northern Trust
6
Northern Trust
Illinois
$20K – – –
Morgan Stanley
7
Morgan Stanley
New York
$19K +$16.9K +15,027 +2,455%
AIM
8
Acrospire Investment Management
Illinois
$13K +$7.97K +7,066 +191%
Manulife (Manufacturers Life Insurance)
9
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
AG
10
Advisor Group
Arizona
$1K – – –
BFA
11
BlackRock Fund Advisors
California
$1K – – –
RFA
12
Reilly Financial Advisors
California
$1K +$1.41K +1,250 New
SCM
13
Sio Capital Management
New York
– -$1.19M -849,905 Closed
VKH
14
Virtu KCG Holdings
New York
– -$33K -23,578 Closed
Wells Fargo
15
Wells Fargo
California
– -$9K -6,250 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– -$1K -528 Closed

VKTX Hedge Fund Activity: Q4 2016 in Review

12 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q4 2016, worth a combined $758K — down 55% from $1.7M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VKTX and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $160K. The largest seller was Sio Capital Management, exiting entirely with an estimated $1.19M sold.

  • 12 institutional investors held Viking Therapeutics (VKTX) as of Q4 2016, down from 14 in Q3 2016.
  • Funds reported $758K of Viking Therapeutics stock for Q4 2016, down 55% quarter-over-quarter.
  • 2 funds opened new Viking Therapeutics positions in Q4 2016 and 4 closed out, a net change of -2 holders.
  • The largest Viking Therapeutics buyer in Q4 2016 was Renaissance Technologies, an estimated $160K added.
  • The largest Viking Therapeutics seller in Q4 2016 was Sio Capital Management, an estimated $1.19M sold.

Based on aggregated 13F filings for Q4 2016.